Table 4.
Characteristics | HR | 95% CI | P |
---|---|---|---|
Number of previous chemotherapy lines | 5.941 | 1.765–19.991 | 0.004 |
Excision of primary lesion | 0.215 | 0.54–0.853 | 0.029 |
ECOG | — | — | 0.364 |
Primary tumor location | — | — | 0.753 |
Bevacizumab | — | — | 0.087 |
Lung metastases | — | — | 0.111 |
ECOG, Eastern Cooperative Oncology Group performance status.